271 related articles for article (PubMed ID: 27060574)
1. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Alwan S; Bandoli G; Chambers CD
Clin Pharmacol Ther; 2016 Jul; 100(1):34-41. PubMed ID: 27060574
[TBL] [Abstract][Full Text] [Related]
2. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
4. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.
Occhiogrosso M; Omran SS; Altemus M
Am J Psychiatry; 2012 Feb; 169(2):134-40. PubMed ID: 22420034
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
[TBL] [Abstract][Full Text] [Related]
6. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
[TBL] [Abstract][Full Text] [Related]
7. Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.
Galbally M; Gentile S; Lewis AJ
CNS Drugs; 2012 Oct; 26(10):813-22. PubMed ID: 22950489
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
Huybrechts KF; Bateman BT; Palmsten K; Desai RJ; Patorno E; Gopalakrishnan C; Levin R; Mogun H; Hernandez-Diaz S
JAMA; 2015 Jun; 313(21):2142-51. PubMed ID: 26034955
[TBL] [Abstract][Full Text] [Related]
9. SSRI antidepressants and persistent pulmonary hypertension in newborns.
Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Hallberg P; Odlind V; Sjöblom V
N Engl J Med; 2006 May; 354(20):2188-90; author reply 2188-90. PubMed ID: 16710910
[No Abstract] [Full Text] [Related]
12. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Reefhuis J; Rasmussen SA; Friedman JM
N Engl J Med; 2006 May; 354(20):2188-90; author reply 2188-90. PubMed ID: 16707761
[No Abstract] [Full Text] [Related]
13. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects.
Ornoy A; Koren G
Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):247-259. PubMed ID: 29345153
[TBL] [Abstract][Full Text] [Related]
15. The effect of perinatal exposures on the infant: antidepressants and depression.
Hanley GE; Oberlander TF
Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
[TBL] [Abstract][Full Text] [Related]
16. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.
Wilson KL; Zelig CM; Harvey JP; Cunningham BS; Dolinsky BM; Napolitano PG
Am J Perinatol; 2011 Jan; 28(1):19-24. PubMed ID: 20607643
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
18. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy.
Mills JL
N Engl J Med; 2006 Feb; 354(6):636-8. PubMed ID: 16467553
[No Abstract] [Full Text] [Related]
19. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
Andrade SE; McPhillips H; Loren D; Raebel MA; Lane K; Livingston J; Boudreau DM; Smith DH; Davis RL; Willy ME; Platt R
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Andrade C
J Clin Psychiatry; 2012 May; 73(5):e601-5. PubMed ID: 22697207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
